Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert C Green, M.D.

Co-Author

This page shows the publications co-authored by Robert Green and Heidi Rehm.
Connection Strength

3.563
  1. GA4GH: International policies and standards for data sharing across genomic research and healthcare. Cell Genom. 2021 Nov 10; 1(2).
    View in: PubMed
    Score: 0.242
  2. Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization. Am J Hum Genet. 2021 12 02; 108(12):2224-2237.
    View in: PubMed
    Score: 0.242
  3. The case for implementing sustainable routine, population-level genomic reanalysis. Genet Med. 2020 04; 22(4):815-816.
    View in: PubMed
    Score: 0.212
  4. Analyzing and Reanalyzing the Genome: Findings from the MedSeq Project. Am J Hum Genet. 2019 07 03; 105(1):177-188.
    View in: PubMed
    Score: 0.205
  5. CORRIGENDUM: ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2017 05; 19(5):606.
    View in: PubMed
    Score: 0.177
  6. A curated gene list for reporting results of newborn genomic sequencing. Genet Med. 2017 07; 19(7):809-818.
    View in: PubMed
    Score: 0.173
  7. Aggregate penetrance of genomic variants for actionable disorders in European and African Americans. Sci Transl Med. 2016 11 09; 8(364):364ra151.
    View in: PubMed
    Score: 0.171
  8. Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. Am J Hum Genet. 2016 07 07; 99(1):246.
    View in: PubMed
    Score: 0.167
  9. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. Am J Hum Genet. 2016 07 07; 99(1):247.
    View in: PubMed
    Score: 0.167
  10. Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. Am J Hum Genet. 2016 06 02; 98(6):1051-1066.
    View in: PubMed
    Score: 0.165
  11. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. Am J Hum Genet. 2016 06 02; 98(6):1067-1076.
    View in: PubMed
    Score: 0.165
  12. A one-page summary report of genome sequencing for the healthy adult. Public Health Genomics. 2015; 18(2):123-9.
    View in: PubMed
    Score: 0.151
  13. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013 Jul; 15(7):565-74.
    View in: PubMed
    Score: 0.135
  14. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med. 2012 Apr; 14(4):405-10.
    View in: PubMed
    Score: 0.124
  15. Primary care providers' responses to unsolicited Lynch syndrome secondary findings of varying clinical significance. Genet Med. 2021 10; 23(10):1977-1983.
    View in: PubMed
    Score: 0.059
  16. A framework for automated gene selection in genomic applications. Genet Med. 2021 10; 23(10):1993-1997.
    View in: PubMed
    Score: 0.059
  17. Discordant results between conventional newborn screening and genomic sequencing in the BabySeq Project. Genet Med. 2021 07; 23(7):1372-1375.
    View in: PubMed
    Score: 0.058
  18. Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights. Genet Med. 2021 07; 23(7):1366-1371.
    View in: PubMed
    Score: 0.058
  19. Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. Genet Med. 2019 May; 21(5):1261-1262.
    View in: PubMed
    Score: 0.051
  20. Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project. Am J Hum Genet. 2019 01 03; 104(1):76-93.
    View in: PubMed
    Score: 0.050
  21. Returning a Genomic Result for an Adult-Onset Condition to the Parents of a Newborn: Insights From the BabySeq Project. Pediatrics. 2019 01; 143(Suppl 1):S37-S43.
    View in: PubMed
    Score: 0.050
  22. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. Genet Med. 2019 05; 21(5):1100-1110.
    View in: PubMed
    Score: 0.049
  23. Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience. Mol Genet Genomic Med. 2018 11; 6(6):898-909.
    View in: PubMed
    Score: 0.048
  24. Reconciling newborn screening and a novel splice variant in BTD associated with partial biotinidase deficiency: a BabySeq Project case report. Cold Spring Harb Mol Case Stud. 2018 08; 4(4).
    View in: PubMed
    Score: 0.048
  25. The BabySeq project: implementing genomic sequencing in newborns. BMC Pediatr. 2018 07 09; 18(1):225.
    View in: PubMed
    Score: 0.048
  26. Automated typing of red blood cell and platelet antigens: a whole-genome sequencing study. Lancet Haematol. 2018 Jun; 5(6):e241-e251.
    View in: PubMed
    Score: 0.048
  27. Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial. Genet Med. 2018 12; 20(12):1544-1553.
    View in: PubMed
    Score: 0.047
  28. A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients. Circ Cardiovasc Genet. 2017 Oct; 10(5).
    View in: PubMed
    Score: 0.046
  29. The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial. Ann Intern Med. 2017 08 01; 167(3):159-169.
    View in: PubMed
    Score: 0.045
  30. Prenatal DNA Sequencing: Clinical, Counseling, and Diagnostic Laboratory Considerations. Prenat Diagn. 2018 01; 38(1):26-32.
    View in: PubMed
    Score: 0.044
  31. Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics. 2017 Feb; 139(2).
    View in: PubMed
    Score: 0.043
  32. Comprehensive red blood cell and platelet antigen prediction from whole genome sequencing: proof of principle. Transfusion. 2016 Mar; 56(3):743-54.
    View in: PubMed
    Score: 0.040
  33. A systematic approach to the reporting of medically relevant findings from whole genome sequencing. BMC Med Genet. 2014 Dec 14; 15:134.
    View in: PubMed
    Score: 0.038
  34. Summarizing polygenic risks for complex diseases in a clinical whole-genome report. Genet Med. 2015 Jul; 17(7):536-44.
    View in: PubMed
    Score: 0.037
  35. The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials. 2014 Mar 20; 15:85.
    View in: PubMed
    Score: 0.036
  36. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genet Med. 2013 Nov; 15(11):860-7.
    View in: PubMed
    Score: 0.035
  37. Development and validation of a computational method for assessment of missense variants in hypertrophic cardiomyopathy. Am J Hum Genet. 2011 Feb 11; 88(2):183-92.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.